BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Morgan Stanley maintains overweight on Biocon
Morgan Stanley has increased target price on Biocon to Rs 1,156 from Rs 889 earlier. Biocon is executing well on biosimilar pipeline. Good momentum in the base business to continue. Re-rating story is making good progress.